DAVID PETROFF: Open Payments
NPI 1134636251 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $197 |
| Janssen Biotech, Inc. | 3 | $53 |
| ABBVIE INC. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Olympus America Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: REZDIFFRA, TREMFYA, MAVYRET, RINVOQ, ENTYVIO, Olympus, SUTAB, IQIRVO.
Industry payments across NY — which companies pay providers there.
